Do you want to join one of the fastest-growing molecular diagnostics startups and develop products that can affect the lives of millions?
BillionToOne, ranked at the top 5% of Y Combinator companies with $250M+ in funding from prominent VC firms, has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold. BillionToOne's QCT molecular counting technology shifts the paradigm of non-invasive prenatal testing (NIPT). The rapidly growing UNITY Screen™ is the only NIPT that can assess fetal risk for both common recessive conditions and aneuploidies from one maternal blood sample. It is also the only fetal antigen NIPT in the US for alloimmunized patients that are at risk of Hemolytic Disease of the Fetus and Newborn (HDFN). Currently, UNITY is being used to test 1 in 25 pregnancies in the US, and this number is continuing to grow 100% YoY. More recently, BillionToOne used the same groundbreaking technology to launch Northstar liquid biopsy assays for cancer, for high-sensitivity therapy selection & precise treatment monitoring.
We are looking for an interdisciplinary Research Associate to perform experiments and assays under the guidance of Senior Scientists. The Research Associate is an on-site position.
Responsibilities:
Requirements:
Nice-To-Haves:
Benefits And Perks:
At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based experience and salary/equity options split that the candidate chooses) (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid paternal leave etc.).
For this position, the base pay range is: $60,000-$80,000 per year.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
BillionToOne’s mission is to revolutionize genetic testing through the development of innovative quantitative diagnostics. BillionToOne's DNA Molecular Counting platform integrates next-generation sequencing technologies with machine learning, w...
28 jobsSubscribe to Rise newsletter